The Apolipoprotein E Knockout Mouse: A Model Documenting Accelerated Atherogenesis In Uremia

Beyond Cholesterol

Epstein, F. H., Steinberg, D. I., Parthasarathy, S., Carew, T. E., Khoo, J. C., & Witztum, J. L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198904063201407 · Cited by 6,425 · see citing works

Spontaneous Hypercholesterolemia and Arterial Lesions in Mice Lacking Apolipoprotein E

Zhang, S. H., Reddick, R. L., Piedrahita, J. A., & Maeda, N. (1992) · Science · doi:10.1126/science.1411543 · Cited by 2,237 · see citing works

Accelerated Atherosclerosis in Prolonged Maintenance Hemodialysis

Lindner, A., Charra, B., Sherrard, D. J., & Scribner, B. H. (1974) · New England Journal of Medicine · doi:10.1056/nejm197403282901301 · Cited by 1,772 · see citing works

Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts

Park, L., Raman, K. G., Lee, K. J., Lu, Y., Ferran, L. J., Chow, W. S., Stern, D. M., & Schmidt, A. M. (1998) · Nature Medicine · doi:10.1038/2012 · Cited by 1,103 · see citing works

Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure

Schwarz, U., Buzello, M., Ritz, E., Stein, G., Raabe, G., Wiest, G., Mall, G., & Amann, K. (2000) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/15.2.218 · Cited by 625 · see citing works

Impaired cerebral cortex development and blood pressure regulation in FGF‐2‐deficient mice

Dono, R., Texidó, G., Dussel, R., Ehmke, H., & Zeller, R. (1998) · The EMBO Journal · doi:10.1093/emboj/17.15.4213 · Cited by 436 · see citing works

Estimation of surface area and length with the orientator

Mattfeldt, T., Mall, G., Gharehbaghi, H., & Möller, P. (1990) · Journal of Microscopy · doi:10.1111/j.1365-2818.1990.tb03036.x · Cited by 376 · see citing works

Endothelin ET A receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice

Barton, M., Haudenschild, C. C., d’Uscio, L. V., Shaw, S., Münter, K., & Lüscher, T. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.24.14367 · Cited by 356 · see citing works

Prevention of Accelerated Atherosclerosis by Angiotensin-Converting Enzyme Inhibition in Diabetic Apolipoprotein E–Deficient Mice

Candido, R., Jandeleit-Dahm, K. A. M., Cao, Z., Nesteroff, S. P., Burns, W. C., Twigg, S. M., Dilley, R. J., Cooper, M. E., & Allen, T. J. (2002) · Circulation · doi:10.1161/01.cir.0000021122.63813.32 · Cited by 261 · see citing works

Effect of 1,25(OH)2 vitamin D3 on glomerulosclerosis in subtotally nephrectomized rats

Schwarz, U., Amann, K., Orth, S. R., Simonaviciene, A., Wessels, S., & Ritz, E. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00951.x · Cited by 248 · see citing works

Cardiac disease in diabetic end-stage renal disease

Foley, R. N., Culleton, B. F., Parfrey, P. S., Harriett, J. D., Kent, G. M., Murray, D. C., & Barré, P. E. (1997) · Diabetologia · doi:10.1007/s001250050825 · Cited by 123 · see citing works

Aortic Changes in Experimental Renal Failure

Amann, K., Wolf, B., Nichols, C., Törnig, J., Schwarz, U., Zeier, M. G., Mall, G., & Ritz, E. (1997) · Hypertension · doi:10.1161/01.hyp.29.3.770 · Cited by 103 · see citing works

Cardiac remodelling in experimental renal failure - an immunohistochemical study

Amann, K. (1998) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/13.8.1958 · Cited by 102 · see citing works

ApoE−/− Mice Develop Atherosclerosis in the Absence of Complement Component C5

Patel, S., Thelander, E. M., Hernandez, M., Montenegro, J., Hassing, H., Burton, C. A., Mundt, S. S., Hermanowski‐Vosatka, A., Wright, S. D., Chao, Y., et al. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5276 · Cited by 68 · see citing works

Soluble Osteopontin and Vascular Calcification in Hemodialysis Patients

Nitta, K., Ishizuka, T., Horita, S., Hayashi, T., Ajiro, A., Uchida, K., Honda, K., Oba, T., Kawashima, A., Yumura, W., et al. (2001) · The Nephron journals/Nephron journals · doi:10.1159/000046119 · Cited by 51 · see citing works

Endothelin receptor antagonists influence cardiovascular morphology in uremic rats

Nabokov, A., Amann, K., Wessels, S., Münter, K., Wagner, J., & Ritz, E. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00290.x · Cited by 44 · see citing works

IL-10, IL-6, and TNF-α: Central factors in the altered cytokine network of uremia—The good, the bad, and the ugly

Stenvinkel, P., Ketteler, M., Johnson, R. J., Lindholm, B., Pecoits‐Filho, R., RIELLA, M. C., Heimbürger, O., Cederholm, T., & Girndt, M. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00200.x · Cited by 933 · see citing works

Trimethylamine <i>N</i> -Oxide, the Microbiome, and Heart and Kidney Disease

Zeisel, S. H., & Warrier, M. (2017) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071816-064732 · Cited by 475 · see citing works

Media Calcification and Intima Calcification Are Distinct Entities in Chronic Kidney Disease

Amann, K. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02120508 · Cited by 385 · see citing works

Kidney Transplantation Halts Cardiovascular Disease Progression in Patients with End-Stage Renal Diseas

Meier‐Kriesche, H., Schold, J. D., Srinivas, T. R., Reed, A., & Kaplan, B. E. (2004) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2004.00573.x · Cited by 342 · see citing works

Chronic kidney disease: a public health priority and harbinger of premature cardiovascular disease

Stenvinkel, P. (2010) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02269.x · Cited by 331 · see citing works

The heart and vascular system in dialysis

Wanner, C., Amann, K., & Shoji, T. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30508-6 · Cited by 302 · see citing works

The molecular mechanisms of hemodialysis vascular access failure

Brahmbhatt, A. N., Remuzzi, A., Franzoni, M., & Misra, S. (2016) · Kidney International · doi:10.1016/j.kint.2015.12.019 · Cited by 263 · see citing works

Coronary Artery Disease in End-Stage Renal Disease

Stenvinkel, P., Pecoits‐Filho, R., & Lindholm, B. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000069165.79509.42 · Cited by 239 · see citing works

Atherosclerosis in CKD: differences from the general population

Drüeke, T. B., & Massy, Z. A. (2010) · Nature Reviews Nephrology · doi:10.1038/nrneph.2010.143 · Cited by 225 · see citing works

Uremia Accelerates both Atherosclerosis and Arterial Calcification in Apolipoprotein E Knockout Mice

Massy, Z. A., Ivanovski, O., Nguyen-Khoa, T., Angulo, J., Szumilak, D., Mothu, N., Phan, O., Daudon, M., Lacour, B., Dru[Combining Diaeresis]eke, T. B., et al. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004060495 · Cited by 203 · see citing works

Association of Kidney Function With Coronary Atherosclerosis and Calcification in Autopsy Samples From Japanese Elders: The Hisayama Study

Nakano, T., Ninomiya, T., Sumiyoshi, S., Fujii, H., Doi, Y., Hirakata, H., Tsuruya, K., Iida, M., Kiyohara, Y., & Sueishi, K. (2009) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.06.034 · Cited by 198 · see citing works

Mechanisms of uremic erythrocyte‐induced adhesion of human monocytes to cultured endothelial cells

Pandolfi, A., Pietro, N. D., Sirolli, V., Giardinelli, A., Silvestre, S. D., Amoroso, L., Tomo, P. D., Capani, F., Consoli, A., & Bonomini, M. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21138 · Cited by 185 · see citing works

Chronic Renal Failure Accelerates Atherogenesis in Apolipoprotein E–Deficient Mice

Bro, S., Bentzon, J. F., Falk, E., Andersen, C. B., Ølgaard, K., & Nielsen, L. B. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000088024.72216.2e · Cited by 170 · see citing works

Magnesium supplementation helps to improve carotid intima media thickness in patients on hemodialysis

Turgut, F. H., Kanbay, M., Metin, M. R., Uz, E., Akçay, A., & Covic, A. C. (2008) · International Urology and Nephrology · doi:10.1007/s11255-008-9410-3 · Cited by 167 · see citing works

Cross-Talk between the Kidney and the Cardiovascular System

Amann, K., Wanner, C., & Ritz, E. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006030204 · Cited by 160 · see citing works

Does Uremia Cause Vascular Dysfunction

Brunet, P., Gondouin, B., Duval-Sabatier, A., Dou, L., Cérini, C., Dignat‐George, F., Jourde‐Chiche, N., Argilés, À., & Burtey, S. (2011) · Kidney & Blood Pressure Research · doi:10.1159/000327131 · Cited by 153 · see citing works

Chronic Kidney Disease as a Coronary Artery Disease Risk Equivalent

Briasoulis, A., & Bakris, G. L. (2013) · Current Cardiology Reports · doi:10.1007/s11886-012-0340-4 · Cited by 152 · see citing works

Inhibition of microbiota-dependent TMAO production attenuates chronic kidney disease in mice

Zhang, W., Miikeda, A., Zuckerman, J. E., Jia, X., Charugundla, S., Zhou, Z., Kaczor‐Urbanowicz, K. E., Magyar, C. E., Guo, F., Wang, Z., et al. (2021) · Scientific Reports · doi:10.1038/s41598-020-80063-0 · Cited by 148 · see citing works

Sevelamer Prevents Uremia-Enhanced Atherosclerosis Progression in Apolipoprotein E–Deficient Mice

Phan, O., Ivanovski, O., Nguyen‐Khoa, T., Mothu, N., Angulo, J., Westenfeld, R., Ketteler, M., Meert, N., Maizel, J., Nikolov, I. G., et al. (2005) · Circulation · doi:10.1161/circulationaha105.541854 · Cited by 148 · see citing works

Calcification of Coronary Intima and Media

Gross, M., Meyer, H.-P., Ziebart, H., Rieger, P., Wenzel, U., Amann, K., Berger, I., Adamczak, M., Schirmacher, P., & Ritz, E. (2006) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01760506 · Cited by 144 · see citing works

Effect of Sevelamer and Calcium-Based Phosphate Binders on Coronary Artery Calcification and Accumulation of Circulating Advanced Glycation End Products in Hemodialysis Patients

Kakuta, T., Tanaka, R., Hyodo, T., Suzuki, H., Kanai, G., Nagaoka, M., Takahashi, H., Hirawa, N., Oogushi, Y., Miyata, T., et al. (2011) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2010.10.055 · Cited by 143 · see citing works

Traditional and non-traditional risk factors as contributors to atherosclerotic cardiovascular disease in end-stage renal disease

Yao, Q., Pecoits‐Filho, R., Lindholm, B., & Stenvinkel, P. (2004) · Scandinavian Journal of Urology and Nephrology · doi:10.1080/00365590410031715 · Cited by 139 · see citing works

Chronic Uremia Stimulates LDL Carbamylation and Atherosclerosis

Apostolov, E. O., Ray, D., Savenka, A. V., Shah, S. V., & Basnakian, A. G. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010040365 · Cited by 132 · see citing works

CKD Accelerates Development of Neointimal Hyperplasia in Arteriovenous Fistulas

小久保, 拓., Ishikawa, N., Uchida, H., Chasnoff, S. E., Xie, X., Mathew, S., Hruska, K. A., & Choi, E. T. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007121312 · Cited by 125 · see citing works

Overview

Ritz, E., & McClellan, W. M. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000115398.92270.30 · Cited by 125 · see citing works

The antioxidant N-acetylcysteine prevents accelerated atherosclerosis in uremic apolipoprotein E knockout mice

Ivanovski, O., Szumilak, D., Nguyen‐Khoa, T., Ruellan, N., Phan, O., Lacour, B., Descamps‐Latscha, B., Dreeke, T. B., & Massy, Z. A. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00332.x · Cited by 117 · see citing works

Identification of cholesterol crystals in plaques of atherosclerotic mice using hyperspectral CARS imaging

Lim, R. S., Suhalim, J. L., Miyazaki‐Anzai, S., Miyazaki, M., Levi, M., Potma, E. O., & Tromberg, B. J. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m018077 · Cited by 110 · see citing works

Vascular Calcification in Chronic Renal Failure

Neven, E., & D’Haese, P. C. (2011) · Circulation Research · doi:10.1161/circresaha.110.225904 · Cited by 101 · see citing works

Hypoxia and Expression of Hypoxia-Inducible Factor in the Aging Kidney

Tanaka, T., Kato, H., Kojima, I., Ohse, T., Son, D., Tawakami, T., Yatagawa, T., Inagi, R., Fujita, T., & Nangaku, M. (2006) · The Journals of Gerontology Series A · doi:10.1093/gerona/61.8.795 · Cited by 97 · see citing works

The role of the kidney in lipid metabolism

Moestrup, S. K., & Nielsen, L. B. (2005) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000169350.45944.d4 · Cited by 98 · see citing works

A calcimimetic (R-568), but not calcitriol, prevents vascular remodeling in uremia

Koleganova, N., Piecha, G., Ritz, E., Schmitt, C. P., & Gross, M. (2008) · Kidney International · doi:10.1038/ki.2008.490 · Cited by 97 · see citing works

Hyperlipidemia induces meibomian gland dysfunction

Bu, J., Wu, Y., Cai, X., Jiang, N., Jeyalatha, M. V., Yu, J., He, X., He, H., Guo, Y., Zhang, M., et al. (2019) · The Ocular Surface · doi:10.1016/j.jtos.2019.06.002 · Cited by 93 · see citing works

Atherosclerosis in chronic kidney disease: the role of macrophages

Kon, V., Linton, M. F., & Fazio, S. (2010) · Nature Reviews Nephrology · doi:10.1038/nrneph.2010.157 · Cited by 89 · see citing works

Protein carbamylation is associated with heart failure and mortality in diabetic patients with end stage renal disease

Drechsler, C., Kalim, S., Wenger, J. B., Suntharalingam, P., Hod, T., Thadhani, R. I., Karumanchi, S., Wanner, C., & Berg, A. (2015) · Kidney International · doi:10.1038/ki.2014.429 · Cited by 82 · see citing works

Increased Infarct Size in Uremic Rats

Dikow, R., Kihm, L., Zeier, M. G., Kapitza, J., Diaeresis]rnig, J. T., Amann, K., Tiefenbacher, C., & Ritz, E. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000130154.42061.c6 · Cited by 83 · see citing works

Atherosclerosis and Vascular Calcification in Chronic Renal Failure

Câmpean, V., Neureiter, D., Varga, I., Runk, F., Reiman, A., Garlichs, C., Achenbach, S., Nonnast-Daniel, B., & Amann, K. (2005) · Kidney & Blood Pressure Research · doi:10.1159/000090182 · Cited by 83 · see citing works

Increased Expression of Adhesion Molecules in Uremic Atherosclerosis in Apolipoprotein-E–Deficient Mice

Bro, S., Moeller, F., Andersen, C. B., Ølgaard, K., & Nielsen, L. B. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000128371.33195.7b · Cited by 78 · see citing works

Iron Sucrose Accelerates Early Atherogenesis by Increasing Superoxide Production and Upregulating Adhesion Molecules in CKD

Kuo, K., Hung, S., Lee, T., & Tarng, D. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013080838 · Cited by 78 · see citing works

Multimodal CARS microscopy determination of the impact of diet on macrophage infiltration and lipid accumulation on plaque formation in ApoE-deficient mice

Lim, R. S., Kratzer, A., Barry, N. P., Miyazaki‐Anzai, S., Miyazaki, M., Mantulin, W. W., Levi, M., Potma, E. O., & Tromberg, B. J. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m003616 · Cited by 75 · see citing works

LDL cholesterol in CKD—to treat or not to treat?

Massy, Z. A., & de Zeeuw, D. (2013) · Kidney International · doi:10.1038/ki.2013.181 · Cited by 73 · see citing works

How Does Minor Renal Dysfunction Influence Cardiovascular Risk and the Management of Cardiovascular Disease?

Pinkau, T., Hilgers, K. F., Veelken, R. A., & Mann, J. F. E. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000107565.17553.71 · Cited by 62 · see citing works

Lipid Abnormalities and Cardiovascular Risk in Renal Disease

Ritz, E., & Wanner, C. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007101128 · Cited by 54 · see citing works

Lipid Changes and Statins in Chronic Renal Insufficiency

Ritz, E., & Wanner, C. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006080919 · Cited by 53 · see citing works

A neutralizing antibody against receptor for advanced glycation end products (RAGE) reduces atherosclerosis in uremic mice

Bro, S., Flyvbjerg, A., Binder, C. J., Bang, C. A., Denner, L. A., Ølgaard, K., & Nielsen, L. B. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.01.015 · Cited by 52 · see citing works

Edema and Congestive Heart Failure from Thiazolidone Insulin Sensitizers—Excess Sodium Reabsoption in the Collecting Duct

Zhang, H., Zhang, A., Kohan, D. E., Nelson, R. D., Gonzales, F., & Yang, T. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005090935 · Cited by 50 · see citing works

Heart and Kidney: Fatal Twins?

Ritz, E. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.01.012 · Cited by 48 · see citing works

Effect of paricalcitol and calcitriol on aortic wall remodeling in uninephrectomized ApoE knockout mice

Becker, L. E., Koleganova, N., Piecha, G., Noronha, I. L., Zeier, M., Geldyyev, A., Kökény, G., Ritz, E., & Gross, M. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00042.2010 · Cited by 47 · see citing works

Expression of Apolipoprotein B in the Kidney Attenuates Renal Lipid Accumulation

Krzystanek, M., Pedersen, T. X., Bartels, E. D., Kjæhr, J., Straarup, E. M., & Nielsen, L. B. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.078006 · Cited by 46 · see citing works

Why is coronary heart disease of uraemic patients so frequent and so devastating?

Amann, K., Ritz, C., Adamczak, M., & Ritz, E. (2003) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg059 · Cited by 45 · see citing works

Vascular Damage in Kidney Disease: Beyond Hypertension

Stinghen, A. E. M., & Pecoits‐Filho, R. (2011) · International Journal of Hypertension · doi:10.4061/2011/232683 · Cited by 43 · see citing works

Pleiotropic effects of the non-calcium phosphate binder sevelamer

Nikolov, I. G., Joki, N., Maizel, J., Lacour, B., Drüeke, T. B., & Massy, Z. A. (2006) · Kidney International · doi:10.1038/sj.ki.5001994 · Cited by 42 · see citing works

Chronic kidney disease is associated with neovascularization and intraplaque hemorrhage in coronary atherosclerosis in elders: results from the Hisayama Study

Nakano, T., Ninomiya, T., Sumiyoshi, S., Onimaru, M., Fujii, H., Itabe, H., Nakashima, Y., Sueishi, K., Tsuruya, K., Oda, Y., et al. (2013) · Kidney International · doi:10.1038/ki.2013.111 · Cited by 41 · see citing works

Increased Atherosclerotic Lesion Formation and Vascular Leukocyte Accumulation in Renal Impairment Are Mediated by Interleukin-17A

Ge, S., Hertel, B., Koltsova, E. K., Sörensen-Zender, I., Kielstein, J. T., Ley, K. F., Haller, H. G., & von Vietinghoff, S. (2013) · Circulation Research · doi:10.1161/circresaha.113.301934 · Cited by 40 · see citing works

Apolipoprotein E knockout as the basis for mouse models of dyslipidemia-induced neuropathy

Hinder, L. M., Vincent, A. M., Hayes, J. M., McLean, L. L., & Feldman, E. L. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.10.002 · Cited by 40 · see citing works

Protective Effect of Chronic Vitamin C Treatment on Endothelial Function of Apolipoprotein E-Deficient Mouse Carotid Artery

Matsumoto, T., d’Uscio, L. V., Eguchi, D., Akiyama, M., Smith, L. A., & Katušić, Z. S. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.049163 · Cited by 40 · see citing works

Pathophysiology Underlying Accelerated Atherogenesis in Renal Disease

Amann, K., Gross, M., & Ritz, E. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000128365.76153.5b · Cited by 40 · see citing works

Decreased expression of klotho gene in uremic atherosclerosis in apolipoprotein E-deficient mice

Yu, J., Deng, M., Zhao, J., & Huang, L. J. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.11.046 · Cited by 39 · see citing works

Resveratrol Supplementation Reduces Aortic Atherosclerosis and Calcification and Attenuates Loss of Aerobic Capacity in a Mouse Model of Uremia

Tomayko, E. J., Cachia, A. J., Chung, H. R., & Wilund, K. R. (2014) · Journal of Medicinal Food · doi:10.1089/jmf.2012.0219 · Cited by 36 · see citing works

T Cell CX3CR1 Mediates Excess Atherosclerotic Inflammation in Renal Impairment

Dong, L., Nordlohne, J., Ge, S., Hertel, B., Melk, A., Rong, S., Haller, H. G., & von Vietinghoff, S. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015050540 · Cited by 36 · see citing works

Antiatherogenic Effects of Angiotensin Receptor Antagonism in Mild Renal Dysfunction

Suganuma, E., Zuo, Y., Ayabe, N., Ma, J., Babaev, V. R., Linton, M. F., Fazio, S., Ichikawa, I., Fogo, A. B., & Kon, V. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005080883 · Cited by 33 · see citing works

Inhibition of the Renin-Angiotensin System Abolishes the Proatherogenic Effect of Uremia in Apolipoprotein E-Deficient Mice

Bro, S., Binder, C. J., Witztum, J. L., Ølgaard, K., & Nielsen, L. B. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.139634 · Cited by 32 · see citing works

Carbamylated LDL

Basnakian, A. G., Shah, S. V., Ok, E., Altunel, E., & Apostolov, E. O. (2010) · Advances in clinical chemistry · doi:10.1016/s0065-2423(10)51002-3 · Cited by 32 · see citing works

Uremia-Specific Effects in the Arterial Media During Development of Uremic Atherosclerosis in Apolipoprotein E–Deficient Mice

Bro, S., Borup, R., Andersen, C. B., Moeller, F., Ølgaard, K., & Nielsen, L. B. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000201060.47945.cb · Cited by 30 · see citing works

Activation of renin-angiotensin system is involved in dyslipidemia-mediated renal injuries in apolipoprotein E knockout mice and HK-2 cells

Ni, J., Ma, K., Wang, C.-X., Liu, J., Zhang, Y., Lv, L., Ni, H.-F., Chen, Y.-X., Ruan, X. Z., & Liu, B. (2013) · Lipids in Health and Disease · doi:10.1186/1476-511x-12-49 · Cited by 29 · see citing works

The Role of Vascular Calcification in Heart Failure and Cognitive Decline

Cheng, H., Wang, J., & Chen, C. (2017) · Pulse · doi:10.1159/000484941 · Cited by 29 · see citing works

Elevated phosphorus modulates vitamin D receptor-mediated gene expression in human vascular smooth muscle cells

Wu-Wong, J. R., Nakane, M., Ma, J., Ruan, X., & Kroeger, P. E. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00492.2006 · Cited by 28 · see citing works

Metabolic disturbances and worsening of atherosclerotic lesions in ApoE-/- mice after cola beverages drinking

Losada, M. E. O., Loughlin, S. M., Rodríguez-Granillo, G. A., Müller, A., Ottaviano, G., Moriondo, M., Cutrìn, J. C., & Milei, J. (2013) · Cardiovascular Diabetology · doi:10.1186/1475-2840-12-57 · Cited by 28 · see citing works

High Fat High Cholesterol Diet (Western Diet) Aggravates Atherosclerosis, Hyperglycemia and Renal Failure in Nephrectomized LDL Receptor Knockout Mice: Role of Intestine Derived Lipopolysaccharide

Ghosh, S. S., Righi, S., Krieg, R. J., Kang, L., Carl, D. E., Wang, J., Massey, H. D., Sica, D. A., Gehr, T. W. B., & Ghosh, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141109 · Cited by 28 · see citing works

Renal function is associated with risk of atrial fibrillation after cardiac surgery

Auer, J., Lamm, G., Weber, T., Berent, R., Ng, C., Porodko, M., & Eber, B. (2007) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(07)70839-5 · Cited by 28 · see citing works

Review: Apolipoprotein E (Apo E) gene polymorphism and coronary heart disease in Asian populations.

Yousuf, F. A., & Iqbal, M. P. (2015) · PubMed · Cited by 27 · see citing works

Extracellular vesicles as mediators of vascular inflammation in kidney disease

Helmke, A., & von Vietinghoff, S. (2016) · World Journal of Nephrology · doi:10.5527/wjn.v5.i2.125 · Cited by 27 · see citing works

CREB/ATF3 signaling mediates indoxyl sulfate-induced vascular smooth muscle cell proliferation and neointimal formation in uremia

Chen, W.-J., Lai, Y., Lee, J.-L., Wu, S., & Hsu, Y. (2020) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2020.11.009 · Cited by 26 · see citing works

CD40–CD154 expression in calcified and non-calcified coronary lesions of patients with chronic renal failure

Câmpean, V., Neureiter, D., Nonnast-Daniel, B., Garlichs, C. D., Gross, M., & Amann, K. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.01.014 · Cited by 26 · see citing works

Why Do Dialysis Patients Develop a Heart of Stone and Bone of China?

Martola, L., Barany, P. F., & Stenvinkel, P. (2005) · Blood Purification · doi:10.1159/000084890 · Cited by 26 · see citing works

The association between lipid metabolism gene polymorphisms and nephropathy in type 2 diabetes: a meta-analysis

Li, T., Shi, Y., Yin, J., Qin, Q., Wei, S., Nie, S., & Liu, L. (2014) · International Urology and Nephrology · doi:10.1007/s11255-014-0843-6 · Cited by 24 · see citing works

Dyslipidemia in chronic kidney disease: pathogenesis and intervention

Piecha, G., Adamczak, M., & Ritz, E. (2009) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.745 · Cited by 24 · see citing works

Atherosclerosis in Dialyzed Patients

Ritz, E. (2004) · Blood Purification · doi:10.1159/000074921 · Cited by 24 · see citing works

Reducing lipids for CV protection in CKD patients—current evidence

Wanner, C., & Ritz, E. (2008) · Kidney International · doi:10.1038/ki.2008.520 · Cited by 23 · see citing works

No aggravation of renal injury in apolipoprotein E knockout mice (ApoE-/-) after subtotal nephrectomy

Buzello, M., Haas, C. S., Hauptmann, F., Gross, M.-L., Faulhaber, J. D., Schultze–Mosgau, S., Ehmke, H., Ritz, E., & Amann, K. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg578 · Cited by 23 · see citing works

Renal dysfunction as a novel risk factor: Microalbuminuria and cardiovascular risk

Ritz, E. (2004) · Kidney International · doi:10.1111/j.1523-1755.2005.09306.x · Cited by 23 · see citing works

Progression of renal disease: new insights into risk factors and pathomechanisms

Gross, M., & Amann, K. (2004) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200405000-00007 · Cited by 23 · see citing works

Effect of treatment with human apolipoprotein A-I on atherosclerosis in uremic apolipoprotein-E deficient mice

Pedersen, T. X., Bro, S., Andersen, M. H., Etzerodt, M., Jauhiainen, M., Moestrup, S., & Nielsen, L. B. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.04.041 · Cited by 22 · see citing works

Apple Peel Supplemented Diet Reduces Parameters of Metabolic Syndrome and Atherogenic Progression in ApoE−/− Mice

González, J., Donoso, W., Sandoval, N., Reyes, M., Gonzalez, P., Gajardo, M., Morales, E., Neira, A., Razmilic, I., Yuri, J. A., et al. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/918384 · Cited by 22 · see citing works

Voluntary Exercise Decreases Atherosclerosis in Nephrectomised ApoE Knockout Mice

Shing, C. M., Fassett, R. G., Peake, J. M., & Coombes, J. S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120287 · Cited by 22 · see citing works

Pathophysiology of Cardiovascular Disease and Renal Failure

Dikow, R., Zeier, M. G., & Ritz, E. (2005) · Cardiology Clinics · doi:10.1016/j.ccl.2005.03.002 · Cited by 22 · see citing works

Osteopontin deficiency dampens the pro-atherogenic effect of uraemia

Pedersen, T. X., Madsen, M., Junker, N., Christoffersen, C., Vikeså, J., Bro, S., Hultgårdh‐Nilsson, A., & Nielsen, L. B. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt049 · Cited by 20 · see citing works

Aging-Related Changes in the Ultrastructure of Hepatocytes and Cardiomyocytes of Elderly Mice Are Enhanced in ApoE-Deficient Animals

Łysek-Gładysińska, M., Wieczorek, A., Jóźwik, A., Walaszczyk, A., Jelonek, K., Szczukiewicz-Markowska, G., Horbańczuk, O. K., Pietrowska, M., Widłak, P., & Gabryś, D. (2021) · Cells · doi:10.3390/cells10030502 · Cited by 19 · see citing works

Increased Calcification and Protein Nitration in Arteries of Chronic Kidney Disease Patients

Guilgen, G., Werneck, M. L., de Noronha, L., Martins, A. P. C., Varela, A., Nakao, L. S., & Pecoits‐Filho, R. (2011) · Blood Purification · doi:10.1159/000330327 · Cited by 19 · see citing works

Lipoprotein(a) accelerates atherosclerosis in uremic mice

Pedersen, T. X., McCormick, S. P. A., Tsimikas, S., Bro, S., & Nielsen, L. B. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m006742 · Cited by 19 · see citing works

Moderate kidney disease inhibits atherosclerosis regression

Ponda, M. P., Barash, I., Feig, J. E., Fisher, E. A. A., & Skolnik, E. Y. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.10.029 · Cited by 18 · see citing works

Farnesyltransferase inhibitor R115777 protects against vascular disease in uremic mice

Nikolov, I. G., Joki, N., Galmiche, A., Nguyen‐Khoa, T., Guerrera, I. C., Guillonneau, F., Ivanovski, O., Phan, O., Maizel, J., Marçon, F., et al. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.02.041 · Cited by 18 · see citing works

Cardiovascular risk in diabetic end-stage renal disease patients

Wang, A. Y.-M. (2011) · Journal of Diabetes · doi:10.1111/j.1753-0407.2011.00113.x · Cited by 18 · see citing works

Characterisation of atherogenic effects of low carbohydrate, high protein diet (LCHP) in apoE/LDLR−/− mice

Kostogrys, R. B., Johann, C., Czyżyńska-Cichoń, I., Franczyk‐Żarów, M., Drahun, A., Maślak, E., Jasztal, A., Gajda, M., Mateuszuk, Ł., Wróbel, T. P., et al. (2015) · The journal of nutrition health & aging · doi:10.1007/s12603-015-0543-7 · Cited by 17 · see citing works

Management of acute intradialytic cardiovascular complications: Updated overview (Review)

Timofte, D., Tănăsescu, M., Balan, D., Tulin, A., Știru, O., Vacaroiu, I., Mihai, A., Popa, C., Cosconel, C.-I., Enyedi, M., et al. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.9713 · Cited by 15 · see citing works

Kidney complications: Why don't statins always work?

Karumanchi, S. A., & Thadhani, R. (2010) · Nature Medicine · doi:10.1038/nm0110-38 · Cited by 16 · see citing works

Effect of uremia on HDL composition, vascular inflammation, and atherosclerosis in wild-type mice

Bang, C. A., Bro, S., Bartels, E. D., Pedersen, T. X., & Nielsen, L. B. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00039.2007 · Cited by 14 · see citing works

Cardiac structure and function in a mouse model of uraemia without hypertension

Bro, S., Bollano, E., Brüel, A., Ølgaard, K., & Nielsen, L. B. (2008) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510802037272 · Cited by 13 · see citing works

Effect of Tocopherol on Atherosclerosis, Vascular Function, and Inflammation in Apolipoprotein E Knockout Mice with Subtotal Nephrectomy

Shing, C. M., Fassett, R. G., Peake, J. M., & Coombes, J. S. (2014) · Cardiovascular Therapeutics · doi:10.1111/1755-5922.12096 · Cited by 13 · see citing works

Gut microbiota-derived metabolite trimethylamine-N-oxide and stroke outcome: a systematic review

Zhang, P., Wang, R., Qu, Y., Guo, Z., & Yang, Y. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1165398 · Cited by 10 · see citing works

Atherosclerosis and vascular calcification in uraemia - a new experimental model.

Ivanovski, O., Nikolov, I. G., Drueke, B. T., & Massy, A. Z. (2007) · PubMed · Cited by 12 · see citing works

No aggravation of renal injury in apolipoprotein E knockout mice (ApoE-/-) after subtotal nephrectomy

Buzello, M., Haas, C. S., Hauptmann, F., Gross, M.-L., Faulhaber, J. D., Schultze–Mosgau, S., Ehmke, H., Ritz, E., & Amann, K. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg578 · Cited by 23 · see citing works

Comprehensive analysis of 1-year-old apolipoprotein E-deficient mice reveals advanced atherosclerosis with vulnerable plaque characteristics.Preprint

Kotsovilis, S., Salagianni, M. L., Varela, A., Davos, C. H., Galani, I. E., & Andreakos, E. (2023) · Research Square · doi:10.21203/rs.3.rs-2510575/v1

Chronic Renal Failure Accelerates Atherogenesis in Apolipoprotein E–Deficient Mice

Bro, S., Bentzon, J. F., Falk, E., Andersen, C. B., Ølgaard, K., & Nielsen, L. B. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000088024.72216.2e · Cited by 170 · see citing works

Establishment and evaluation of uremic atherosclerosis models in ApoE~(-/-) mice

Huang, L. (2009) · Di-san junyi daxue xuebao

the Development of Atherosclerosis in Apolipoprotein E– Knockout Mice

Tedgui, A., Groux, H., Mallat, Z., Gojová, A., Brun, V., Esposito, B., Fournier, N., Cottrez, F., Knockout Mice−atherosclerosis In Apolipoprotein, E., Gojová, A., et al. (2014)